AD Knowledge Portal

A one-of-a-kind platform for accessing data, analyses and research toolkits to accelerate Alzheimer’s disease discoveries and their translation to clinical outcomes. The portal supports 13 national research programs dedicated to identifying new biomarkers of Alzheimer’s disease, diversifying and reinvigorating the drug development pipeline, and understanding the key molecular mechanisms of neurodegenerative symptoms.

Launch AD Knowledge Portal

The AD Knowledge Portal was developed as part of the Accelerating Medicines Partnership in Alzheimer's Disease (AMP‐AD) program between the National Institutes of Health (NIH) and several nonprofit organizations and pharmaceutical companies.

Powered by Synapse.